Jagdish Whitten was on a run in July 2023 when a car hit him as he crossed a busy San Francisco street. Whitten, then 25, described doing “a little flip” over the vehicle and landing in the street before getting himself to the curb. Concerned onlookers called an ambulance. But Whitten instead had friends pick…
By MIKE MAGEE The leaders of America’s scientific community seem genuinely surprised by the actions of the past three weeks. They expected to be spared the wrath of Trump because they believed that “Americans of all political persuasions have respect for science and celebrate its breakthroughs.” Maybe so. But that is an inadequate defense against a…
Sarah Emond on Prescription for Better Access. “Nothing will have more impact on workers’ comp than significant cuts to Medicaid.”“So one can only assume that we’re not picking flu strains this year.”SLR: Palliative care effectiveness/cost effectivenessNBER: Economics of Artificial Intelligence
This week, UnitedHealth Group faced two new investigations from federal lawmakers. The first was a senator’s probe into its Medicare Advantage billing practices, and the second was a Congressman’s investigation into a decline in care quality at Optum-owned clinics in New York. The post UnitedHealth Hit with 2 New Federal Probes in 1 Week appeared…
President Donald Trump recently announced an executive order on IVF. But it doesn’t actually do much yet. Rather, it’s asking for a list of recommendations to protect IVF access. The post Trump’s IVF Executive Order Doesn’t Actually Achieve Much — Yet appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
Zevra Therapeutics received a priority review voucher for Miplyffa, the first FDA-approved treatment for the rare metabolic disorder Niemann Pick disease type C. Though Zevra has other drug candidates that could benefit from the voucher, the biotech is selling it to an undisclosed buyer. The post Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug…
Our updated explainer provides an overview of comprehensive managed care, the most common way states deliver Medicaid services to enrollees.
This volume discusses the spread of race-based vaccine myths and shifts in health communication from fact-checking to fostering open dialogue. It also explains common misconceptions about heart attack treatment and prevention, a new scientific journal that questions established science, and gaps in research standards for AI chatbots used in healthcare.
For decades, EMS has relied on blood component therapy, which was favored for its longer shelf life, efficiency, and lower risk of transfusion reactions. However, emerging data suggests that whole blood transfusion in the field could significantly improve survival rates, particularly in rural and remote areas where longer transport times pose additional risks. The post…